John Lee
2020 - PhaseBio Pharmaceuticals
In 2020, John Lee earned a total compensation of $910.2K as Chief Medical Officer at PhaseBio Pharmaceuticals, a 17% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $150,000 |
---|---|
Option Awards | $328,000 |
Salary | $423,067 |
Other | $9,159 |
Total | $910,226 |
Lee received $423.1K in salary, accounting for 46% of the total pay in 2020.
Lee also received $150K in non-equity incentive plan, $328K in option awards and $9.2K in other compensation.
Rankings
In 2020, John Lee's compensation ranked 9,009th out of 13,090 executives tracked by ExecPay. In other words, Lee earned more than 31.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 9,009 | 31st |
Manufacturing | 3,850 | 32nd |
Chemicals And Allied Products | 1,555 | 31st |
Drugs | 1,358 | 30th |
Pharmaceutical Preparations | 1,005 | 31st |
Lee's colleagues
We found two more compensation records of executives who worked with John Lee at PhaseBio Pharmaceuticals in 2020.
News
Marathon Patent Group CFO Hugh Gallagher receives $4.8M in 2022
June 23, 2023
Decibel Therapeutics CEO Laurence Reid's 2022 pay jumps 54% to $1.2M
April 28, 2023
PhaseBio Pharmaceuticals CEO Jonathan Mow's 2021 pay slips 13% to $1.5M
April 22, 2022
PhaseBio Pharmaceuticals CEO Jonathan Mow's 2019 pay jumps 102% to $1.2M
April 24, 2020
PhaseBio Pharmaceuticals CEO Jonathan Mow's 2018 pay jumps 37% to $596K
April 5, 2019